Rubric Capital Management (New York)’s Protagonist Therapeutics PTGX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-198,059	Closed	-$6.86M	–	72
2024 Q2	$6.86M	Hold	198,059	–	–	0.18%	56
2024 Q1	$5.73M	Buy	+198,059	New	+$5.73M	0.17%	62